CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...
For Fourth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / July...
For Fourth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / July...
KELOWNA, BC / ACCESSWIRE / July 11, 2023 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
KELOWNA, BC / ACCESSWIRE / July 11, 2023 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
PHILADELPHIA, PA / ACCESSWIRE / July 11, 2023 / CGFNS International announced today that it has appointed Lea Sims, a...
PHILADELPHIA, PA / ACCESSWIRE / July 11, 2023 / CGFNS International announced today that it has appointed Lea Sims, a...
AlayaCare Bolsters Leadership Team to Accelerate Growth and US ExpansionTORONTO, ON / ACCESSWIRE / July 11, 2023 / AlayaCare, an...
AlayaCare Bolsters Leadership Team to Accelerate Growth and US ExpansionTORONTO, ON / ACCESSWIRE / July 11, 2023 / AlayaCare, an...
SHELTON, CT / ACCESSWIRE / July 11, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development...
Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression TreatmentMALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
Jupiter Wellness, Inc Jupiter Wellness as it Deploys a Multi-Channel Strategy to Bring Safety Shot to MarketJUPITER, FL, July 11,...
The Phase 3 clinical trials achieved the co-primary and all secondary endpoints and subjects completed the 16-week treatment with no...
CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
CHARLOTTESVILLE, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW)Â ("Adial" or the "Company"), a clinical-stage biopharmaceutical...
Lasker Prize winning researcher and serial entrepreneur will remain an advisor to the CompanyBASKING RIDGE, N.J., July 11, 2023 (GLOBE...
-- Initiation of Stage 2 Approved by Independent Data Safety Monitoring Board Following Review of Stage 1 Safety and Tolerability...
The trial will assess the safety and preliminary efficacy of Salarius’ novel targeted protein degrader SP-3164; Patient dosing expected to...